Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum

Infection and Immunity

Volumn 73, Issue 4, 2005, Pages 2109-2115

  Hillier, Collette J ^a   Ware, Lisa A ^a   Barbosa, Arnoldo ^a   Angov, Evelina ^a   Lyon, Jeffrey A ^a   Heppner, D Gray ^a   Lanar, David E ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; EPITOPE; GAMMA INTERFERON; LIVER STAGE ANTIGEN 1; MALARIA VACCINE; PARASITE ANTIGEN; PLASMODIUM FALCIPARUM VACCINE; UNCLASSIFIED DRUG; LIVER STAGE SPECIFIC ANTIGEN, PLASMODIUM; LIVER STAGE-SPECIFIC ANTIGEN, PLASMODIUM; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; RECOMBINANT VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; BACTERIAL CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; GOOD MANUFACTURING PRACTICE; INTERFERON PRODUCTION; LIFE CYCLE; MALARIA FALCIPARUM; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN STABILITY; RABBIT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BLOOD; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ESCHERICHIA COLI; FEMALE; INTERFERON TYPE II; MALARIA VACCINES; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

EID: 16244415171     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.4.2109-2115.2005     Document Type: Article

References (22)

1. Aidoo, M., A. Lalvani, C. E. M. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, F. Gotch, D. A. Fidock, M. Takiguchi, K. J. H. Robson, B. M. Greenwood, P. Druilhe, H. C. Whittle, and A. V. S. Hill. 1995. Identification of conserved antigenic components for a cytotoxic T-lymphocyte-inducing vaccine against malaria. Lancet 345:1003-1007.
2. Angov, E., B. M. Aufiero, A. M. Turgeon, M. Van Handenhove, C. F. Ockenhouse, K. E. Kester, D. S. Walsh, J. S. McBride, M. C. Dubois, J. Cohen, J. D. Haynes, K. H. Eckels, D. G. Heppner, W. R. Ballou, C. L. Diggs, and J. A. Lyon. 2003. Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-1(42) malaria vaccine. Mol. Biochem. Parasitol. 128:195-204.
3. Connelly, M., C. L. King, K. Bucci, S. Walters, B. Genton, M. P. Alpers, M. Hollingdale, and J. W. Kazura. 1997. T-cell immunity to peptide epitopes of liver-stage antigen-1 in an area of Papua New Guinea in which malaria is holoendemic. Infect. Immun. 65:5082-5087.
4. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453-1462.
5. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, D. M. Gordon, A. Oloo, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97-112.
6. Dutta, S., P. V. Lalitha, L. A. Ware, A. Barbosa, J. K. Moch, M. A. Vassell, B. B. Fileta, S. Kitov, N. Kolodny, D. G. Heppner, J. D. Haynes, and D. E. Lanar. 2002. Purification and characterization of the refolded ectodomain of the apical membrane antigen-1 of Plasmodium falciparum expressed in Escherichia coli. Infect. Immun. 70:3101-3110.
7. Fidock, D. A., H. Gras-Masse, J. P. Lepers, K. Brahimi, L. Benmohamed, S. Mellouk, C. Guerin-Marchand, A. Londono, L. Raharimalala, J. F. Meis, et al. 1994. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 153:190-204.
8. + T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-γ ELISPOT. Parasite Immunol. 22:501-514.
9. Hill, A. V., C. E. M. Allsopp, D. Kwiatkowski, N. M. Anstey, P. Twumasi, P. A. Rowe, S. Bennett, D. Brewster, A. J. McMichael, and B. M. Greenwood. 1991. Common West African HLA antigens are associated with protection from severe malaria. Nature 352:595-600.
10. Hill, A. V., J. Elvin, A. C. Willis, M. Aidoo, C. E. M. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. M. Townsend, A. J. McMichael, and H. C. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439.
11. Hollingdale, M. R., M. Aikawa, C. T. Atkinson, W. R. Ballou, G. X. Chen, J. Li, J. F. Meis, B. Sina, C. Wright, and J. D. Zhu. 1990. Non-CS preerythrocytic protective antigens. Immunol. Lett. 25:71-76.
12. John, C. C., A. M. Moorman, P. O. Sumba, A. V. Ofila, D. C. Pregibon, and J. W. Kazura. 2004. Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. Infect. Immun. 72:5135-5142.
13. Krzych, U., J. A. Lyon, T. Jareed, I. Schneider, M. R. Hollingdale, D. M. Gordon, and W. R. Ballou. 1995. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155:4072-4077.
14. Kurtis, J. D., D. E. Lanar, M. Opollo, and P. E. Dufly. 1999. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect. Immun. 67:3424-3429.
15. Luty, A. J., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, S. Ulbert, F. Migot-Nabias, B. Dubois, P. Deloron, and P. Kremsner. 1998. Parasite antigen-specific interieukin-10 and antibody responses predict accelerated parasite clearance in Plasmodium falciparum malaria. Eur. Cytokine Network 9:639-646.
16. a. National Research Council, Institute of Laboratory Animal Research, Commission on Life Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
17. Prieur, E., S. C. Gilbert, J. Schneider, A. C. Moore, E. G. Sheu, N. Goonetilleke, L. J. H. Robson, and A. V. S. Hill. 2004. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. Proc. Natl. Acad. Sci. USA 101:290-295.
18. Stoute, J. A., M. Slaoui, D. G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garcon, U. Krzych, M. Marchand, W. R. Ballou, J. D. Cohen, et al. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336:86-91.
19. Terzakis, J. A., J. P. Vanderberg, D. Foley, and S. Shustak. 1979. Exoerythrocytic merozoites of Plasmodium berghei in rat hepatic Kupffer cells. J. Protozool. 26:385-389.
20. Tine, J. A., D. E. Lanar, D. Smith, B. T. Wellde, P. Schultheiss, L. A. Ware, E. Kauffman, R. A. Wirtz, C. de Taisne, G. S. N. Hui, S. P. Chang, P. Church, D. C. Kaslow, M. R. Hollingdale, D. C. Kaslow, S. Hoffman, K. P. Guito, W. R. Ballou, J. C. Sadoff, and E. Paoletti. 1996. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infect. Immun. 64:3833-3844.
21. Yang, C., Y. P. Shi, V. Udhayakumar, M. P. Alpers, M. M. Povoa, W. A. Hawley, W. E. Collins, and A. A. Lal. 1995. Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 71:291-294.
22. Zhu, J., and M. R. Hollingdale. 1991. Structure of Plasmodium falciparum liver stage antigen-1. Mol. Biochem. Parasitol. 48:223-226.